IRIS
SPALLONE, VINCENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.458
EU - Europa 5.350
AS - Asia 4.067
SA - Sud America 713
Continente sconosciuto - Info sul continente non disponibili 491
AF - Africa 92
OC - Oceania 86
Totale 54.257
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.079
IT - Italia 2.015
SG - Singapore 1.664
CN - Cina 740
UA - Ucraina 560
DE - Germania 542
BR - Brasile 517
FR - Francia 420
RU - Federazione Russa 381
IE - Irlanda 352
VN - Vietnam 339
HK - Hong Kong 305
KR - Corea 257
GB - Regno Unito 253
PL - Polonia 176
BD - Bangladesh 168
FI - Finlandia 168
CA - Canada 162
SE - Svezia 136
MX - Messico 131
JP - Giappone 116
NL - Olanda 101
IN - India 94
ES - Italia 78
AU - Australia 70
ID - Indonesia 59
TR - Turchia 51
AR - Argentina 45
CO - Colombia 38
TH - Thailandia 37
ZA - Sudafrica 35
IQ - Iraq 31
MY - Malesia 31
PH - Filippine 31
EC - Ecuador 29
CH - Svizzera 26
CL - Cile 26
KG - Kirghizistan 24
PE - Perù 24
PK - Pakistan 22
BE - Belgio 20
CR - Costa Rica 20
AT - Austria 17
EG - Egitto 16
IR - Iran 16
NZ - Nuova Zelanda 15
UZ - Uzbekistan 15
HU - Ungheria 14
JM - Giamaica 13
DK - Danimarca 12
EU - Europa 12
RO - Romania 12
VE - Venezuela 12
CZ - Repubblica Ceca 10
BG - Bulgaria 9
GR - Grecia 9
NI - Nicaragua 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
GT - Guatemala 8
IL - Israele 8
MA - Marocco 8
TW - Taiwan 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
KE - Kenya 7
LT - Lituania 7
SA - Arabia Saudita 7
BB - Barbados 6
HN - Honduras 6
JO - Giordania 6
UY - Uruguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
EE - Estonia 4
MD - Moldavia 4
MN - Mongolia 4
NP - Nepal 4
PR - Porto Rico 4
SV - El Salvador 4
AM - Armenia 3
CG - Congo 3
GE - Georgia 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BZ - Belize 2
CM - Camerun 2
HR - Croazia 2
ME - Montenegro 2
NG - Nigeria 2
NO - Norvegia 2
SI - Slovenia 2
Totale 53.763
Salva come PNG Salva come JPEG
Città #
Wilmington 11.066
Woodbridge 10.991
Houston 10.011
Singapore 997
Ashburn 975
Fairfield 804
Chandler 725
San Jose 605
Ann Arbor 586
Jacksonville 413
Dublin 330
Hong Kong 294
Beijing 293
Seattle 287
Cambridge 265
Rome 258
Council Bluffs 247
Medford 247
New York 230
Dearborn 215
Los Angeles 158
Santa Clara 154
Kraków 153
The Dalles 146
Milan 123
Lawrence 117
Ho Chi Minh City 112
Redwood City 104
Dallas 94
Tokyo 88
Menlo Park 80
Buffalo 79
Lauterbourg 78
Hanoi 70
Helsinki 68
Atlanta 56
San Diego 52
São Paulo 50
Moscow 45
Florence 44
Bologna 42
Phoenix 40
Naples 39
Toronto 39
London 38
Mülheim 38
Denver 37
Jakarta 36
Boardman 35
Falls Church 34
Mountain View 33
Orem 31
Brooklyn 29
Nuremberg 29
Bangkok 28
Chicago 28
Zhengzhou 28
Columbus 27
Montreal 27
Redondo Beach 27
Palo Alto 26
Bari 25
Sydney 25
Palermo 24
Verona 24
University Park 23
Boston 22
Munich 22
Santiago 22
Da Nang 21
Detroit 21
Kansas City 21
Lima 21
Newark 21
Ankara 20
Dong Ket 20
Guangzhou 20
Philadelphia 20
Barcelona 19
Kunming 19
Nanjing 19
Frankfurt am Main 18
Miami 18
Shanghai 18
Brasília 17
Calgary 17
Genoa 17
Padova 17
Turin 17
Warsaw 17
Washington 17
Brussels 16
Modena 16
Norwalk 16
Queens 16
Charlotte 15
Mumbai 15
Trieste 15
Amsterdam 14
Johannesburg 14
Totale 43.140
Salva come PNG Salva come JPEG
Nome #
Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes 1.389
Position Statement sull’appropriatezza nella prescrizione degli esami di laboratorio in diabetologia 998
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation 986
Neuropatia Diabetica 669
Determinants of Orthostatic Hypotension in Type 2 Diabetes: Is Cardiac Autonomic Neuropathy the Main Factor? 623
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 593
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 563
Raccomandazioni sull’uso dei test cardiovascolari nella diagnosi di neuropatia autonomica diabetica 549
Diagnostic value of different autonomic symptoms assessed by COMPASS 31 for cardiovascular autonomic neuropathy and diabetic polyneuropathy 544
Il trattamento della psoriasi nell’adulto. Linea guida 25. 543
Neuropatia Diabetica 535
Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction? 531
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 526
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 525
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 524
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 510
Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? 508
Neuropatia diabetica autonomica, pressione arteriosa e funzione renale (Valsalva Lecture) 505
Combination Therapy in Diabetic Neuropathy 502
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy 501
Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic 500
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 499
Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes 498
Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. 494
1965-2015, 1991-2015. 50 years of the EASD, 25 years of Neurodiab. Enduring friendship. A legacy for the future 494
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 494
Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy 490
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 487
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 484
Effects of somatostatin on established induced ketosis 483
Diagnosis of cardiovascular autonomic neuropathy in diabetes 482
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone 481
Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics 480
Neuropatia e assistenza al diabetico 476
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 476
GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). 474
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 474
Twenty-four-hour pattern of blood pressure and spectral analysis of heart rate variability in diabetic patients with various degrees of autonomic neuropathy. Comparison to standard cardiovascular tests. 471
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 466
Benfotiamine: Commentary and update on recent studies 466
Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes 465
Neuropatia diabetica in Italia 465
Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy 464
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy 460
Carbohydrate metabolism in hypertension: influence of treatment 460
Neuropathy in chronic kidney disease 459
Autonomic neuropathy: Clinical and instrumental findings 456
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. 454
Psychopathology and dietary restriction: A comparison between eating disorders and Type 1 diabetes 452
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 452
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 451
Prevenzione degli eventi avversi correlati alla presenza di complicanze del diabete (ipotensione ortostatica, danno renale acuto da mezzo di contrasto e ulcere da pressione) 451
Autonomic neuropathy and secondary hyperparathyroidism in uraemia 448
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 447
Study of conduction velocity in diabetic with autonomic neuropathy. 444
The relationship of autonomic neuropathy to other diabetic complications 444
Methods of investigation for cardiac autonomic dysfunction in human research studies 443
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 443
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 440
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 440
Management of painful diabetic neuropathy: guideline guidance or jungle? 438
Perspectives in Diabetic Neuropathy: Update on Diagnostic Criteria and Treatment Options 437
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 436
Might genetics play a role in understanding and treating diabetic polyneuropathy? 435
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 433
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 432
Why not to use the handgrip test in the assessment of cardiovascular autonomic neuropathy among patients with diabetes mellitus? 431
Efficacy and safety of lacosamide in painful diabetic neuropathy 429
MicroRNA genetic variations: association with type 2 diabetes 429
Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus 427
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 425
Diabetic autonomic neuropathy 422
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 422
Painful and painless diabetic neuropathy: one disease or two? 421
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 420
Should we avoid the handgrip test in the assessment of cardiovascular autonomic neuropathy in diabetic patients? Exploratory factor analysis 420
Improvement in peripheral and autonomic neuropathy during 18 months of treatment with subcutaneous continuous insulin infusion in type 1 diabetics 413
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 412
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 412
Costruire l'identità del nutrizionista 411
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 411
Le nuove frontiere della nutrizione. 407
Reply to Circulating erythropoietin in diabetes mellitus. 403
Il corretto iter diagnostico della Neuropatia Diabetica 402
Reappraisal of the diagnostic role of orthostatic hypotension in diabetes 401
Relationship between hyperfunction of antral G cells (AGCH) and autonomic neuropathy (AN) in diabetic patients 400
Comparative study of periferal and autonomic neuropathy in diabetes 398
Painful Diabetic Polyneuropathy: Approach to Diagnosis and Management 395
Time for a Consensus Conference on pain in neurorehabilitation. 391
Novità in Endocrinologia. Calcificazione vascolare e osteolisi nella neuropatia diabetica - il legame mancante è il RANK-L? 387
Screening e trattamento della neuropatia diabetica 385
A common polymorphism in MIR155 gene promoter region is associated with a lower risk to develop type 2 diabetes 379
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 377
Terapia farmacologica della neuropatia diabetica dolorosa 377
Blood Pressure Variability and Autonomic Dysfunction 377
Microvascular complications in children and adolescents with type 1 diabetes 375
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 374
Disfunzione autonomica gastro-enterica e genito-urinaria 373
Impaired alpha cell function in conditions with cortisol deficiency 371
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 366
Totale 47.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.644
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.076 0 0 0 95 87 168 60 68 73 93 90 342
2022/20232.062 195 131 103 235 182 410 174 145 197 55 141 94
2023/20241.016 100 54 72 78 105 175 49 69 55 75 69 115
2024/20252.896 135 664 304 202 136 146 257 145 374 211 213 109
2025/20265.525 297 194 516 460 488 200 695 508 617 435 837 278
2026/20272.503 737 395 1.097 274 0 0 0 0 0 0 0 0
Totale 54.257